Induction of Stem-Cell-Derived Cardiomyogenesis by Fibroblast Growth Factor 10 (FGF10) and Its Interplay with Cardiotrophin-1 (CT-1)

SIMPLE SUMMARY: Cardiovascular diseases are worldwide one of the leading contributors of mortality, and among multiple therapeutic approaches, stem cell therapy has been introduced as a robust therapeutic strategy to alleviate related symptoms and restore cardiac functions. Prior to this, however, f...

Descripción completa

Detalles Bibliográficos
Autores principales: Khosravi, Farhad, Ahmadvand, Negah, Wartenberg, Maria, Sauer, Heinrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026462/
https://www.ncbi.nlm.nih.gov/pubmed/35453733
http://dx.doi.org/10.3390/biology11040534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026462/
https://www.ncbi.nlm.nih.gov/pubmed/35453733
http://dx.doi.org/10.3390/biology11040534

Ejemplares similares